Table 2.
Global DALYs resulting from incident RR-TB in 2020 by country grouping
| Region | RR-TB DALYs per 100,000 | DALYs per RR-TB case | Total RR-TB DALYs (millions) | Percent of global RR-TB burden (%) |
|---|---|---|---|---|
| African Region | 152.0 (111.4, 204.4) | 23.0 (18.4, 27.3) | 1.72 (1.26, 2.32) | 24.8 (20.1, 31.0) |
| Region of the Americas | 13.7 (9.0, 20.1) | 13.9 (10.6, 17.2) | 0.14 (0.09, 0.21) | 2.0 (1.4, 2.8) |
| Eastern Mediterranean Region | 83.6 (41.8, 138.2) | 14.8 (10.5, 19.4) | 0.63 (0.32, 1.04) | 9.0 (5.2, 14.2) |
| European Region, excluding former Soviet Uniona | 3.2 (2.4, 4.1) | 11.7 (8.7, 14.7) | 0.02 (0.01, 0.03) | 0.3 (0.2, 0.4) |
| Former Soviet Union countriesa | 290.7 (225.2, 369.1) | 14.2 (11.1, 17.4) | 0.87 (0.68, 1.11) | 12.6 (10.5, 15.0) |
| South-East Asia Region | 126.1 (99.9, 153.4) | 19.6 (15.9, 23.3) | 2.57 (2.04, 3.13) | 37.2 (32.6, 41.9) |
| Western Pacific Region | 50.5 (34.6, 71.1) | 12.2 (8.8, 15.8) | 0.97 (0.67, 1.37) | 14.0 (11.2, 17.5) |
| High MDR/RR-TB burden | 129.8 (101.0, 161.6) | 17.0 (13.3, 20.3) | 5.96 (4.63, 7.42) | 85.9 (82.5, 88.4) |
| Global | 88.8 (70.7, 109.2) | 17.3 (13.8, 20.6) | 6.93 (5.52, 8.53) | 100 (100, 100) |
DALYs disability-adjusted life years, RR-TB rifampicin-resistant tuberculosis.
Values in parentheses represent 95% uncertainty intervals.
aFormer Soviet Union countries reported separately from the European Region, given their different epidemiology of tuberculosis drug resistance. High MDR/RR-TB countries include Angola, Azerbaijan, Bangladesh, Belarus, China, Democratic Republic of Congo, Indonesia, India, Kazakhstan, Kyrgyzstan, Moldova, Myanmar, Mongolia, Mozambique, Nigeria, Nepal, Pakistan, Peru, Philippines, Papua New Guinea, North Korea, Russia, Somalia, Tajikistan, Ukraine, Uzbekistan, Viet Nam, South Africa, Zambia, and Zimbabwe.